Biohaven Ltd.
BHVN
$14.85
-$2.35-13.66%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 104.33M | 95.95M | 89.24M | 85.68M | 80.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 790.46M | 740.63M | 702.31M | 676.99M | 609.37M |
| Operating Income | -790.46M | -740.63M | -702.31M | -676.99M | -609.37M |
| Income Before Tax | -766.11M | -887.82M | -845.69M | -804.86M | -750.36M |
| Income Tax Expenses | 859.00K | 775.00K | 735.00K | -525.00K | -3.75M |
| Earnings from Continuing Operations | -766.97 | -888.60 | -846.42 | -804.34 | -746.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -766.97M | -888.60M | -846.42M | -804.34M | -746.61M |
| EBIT | -790.46M | -740.63M | -702.31M | -676.99M | -609.37M |
| EBITDA | -781.78M | -731.98M | -694.46M | -669.70M | -602.54M |
| EPS Basic | -7.66 | -9.37 | -9.39 | -9.35 | -9.16 |
| Normalized Basic EPS | -4.84 | -4.70 | -4.72 | -4.78 | -4.68 |
| EPS Diluted | -7.66 | -9.37 | -9.39 | -9.35 | -9.16 |
| Normalized Diluted EPS | -4.84 | -4.70 | -4.72 | -4.78 | -4.68 |
| Average Basic Shares Outstanding | 399.74M | 385.14M | 364.80M | 343.67M | 317.62M |
| Average Diluted Shares Outstanding | 399.74M | 385.14M | 364.80M | 343.67M | 317.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |